Riskpilot← Back to searchSign inGet full accessTrialy AB
ABActiveOrg 5591207872Järntorget 3Media representation · NACE 7312Est. 20171 employees
Revenue 2025
SEK 435K
-58% vs 2024
EBITDA margin
5.3%
-86% vs 2024
Equity ratio
30.4%
Financial strength
Net profit 2025
SEK 21K
-41% vs 2024
| Revenue | SEK 435K | -58% |
| EBITDA | SEK 23K | -86% |
| Net profit | SEK 21K | -41% |
| Total assets | SEK 465K | -19% |
| Equity | SEK 142K | +18% |
| Employees | 1 | — |
Legal name
Trialy AB
Org number
5591207872
Legal form
Aktiebolag
NACE code
7312 · Media representation
Founded
1 augusti 2017
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-01-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Erbjuda IT-lösningar som förenklar utförandet av olika typer av forskning.
Address
Järntorget 3
Email
erik.granberg@enkatfabriken.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 221 | 821 | 1 170 | 1 035 | 435 |
| Staff expenses | — | — | −112 | −80 | −3 |
| EBITDA | −125 | −194 | 435 | 169 | 23 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | −125 | −194 | 435 | 169 | 23 |
| Net financials | −1 | −1 | −3 | −3 | −2 |
| Profit before tax | −100 | 25 | 32 | 36 | 21 |
| Tax | −0 | −0 | — | — | — |
| Net profit | −100 | 25 | 32 | 36 | 21 |
| Item | 2020 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 120 | 552 | 734 | 572 | 465 |
| Equity | 29 | 53 | 85 | 121 | 142 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 91 | 499 | 650 | 451 | 323 |
| Total debt | 91 | 499 | 650 | 451 | 323 |
EBITDA margin
5.3%
This company
15.8%
Market median
-66% vs market
20202025
Equity ratio
30.4%
This company
38.2%
Market median
+20% vs market
20202025
Return on equity
14.9%
This company
18.4%
Market median
+19% vs market
20202025
Net profit margin
4.9%
This company
8.1%
Market median
-40% vs market
20202025
Asset turnover
0.93×
This company
1.12×
Market median
+17% vs market
20202025
Debt / equity
2.28×
This company
0.62×
Market median
-268% vs market
20202025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-02-01 – 2025-01-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-02-01 – 2024-01-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-02-01 – 2023-01-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-01-01 – 2022-01-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
NG Auditor Substitute | Auditor Substitute | 2024 |
PG Audit | Audit | 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2021 | |
| Board of Directors | 2021 | |
| Former (3) | ||
| Board of Directors | 2021 – 2021 | |
| Chairman | 2021 – 2021 | |
| Deputy Board Member | 2020 – 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Lysio Research AB
Trialy AB Board members of Trialy AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nils Gustaf Peter Önnheim | Auditor Substitute | 0 companies |
| Per Gustaf Önnheim | Audit | 0 companies |
| Vilhelm Joey Falck | Board of Directors | 0 companies |
| Erik Adam Håkan Hultin | Chairman | 0 companies |
| Gustav Daniel Sturesson | Deputy Board Member | 0 companies |
| Erik Gunnar Viktor Granberg | Board of Directors | 0 companies |
| Max Johan Roland Jönsson | Deputy Board Member | 0 companies |